DNA repair and stemness determine the sensitizing effect of CHK1, RAD51 and PARP1 inhibition in TNBC

被引：0
|
作者：
Meyer, F. [1 ]
Becker, S. [1 ]
Niecke, A. [1 ]
Riepen, B. [1 ]
Zielinski, A. [1 ]
Werner, S. [2 ]
Peitzsch, C. [3 ]
Hein, L. [3 ]
Dubrovska, A. [3 ]
Wikmann, H. [2 ]
Windhorst, S. [4 ]
Goy, Y. [5 ]
Parplys, A. C. [1 ]
Petersen, C. [5 ]
Rothkamm, K. [1 ]
Borgmann, K. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf UKE, Radiat Biol Expt Radiooncol, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf UKE, Tumorbiol, Hamburg, Germany
[3] Onkoray, Inst Radiat Biol, Dresden, Germany
[4] Univ Med Ctr Hamburg Eppendorf UKE, Biochem, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf UKE, Radiotherapy, Hamburg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)30689-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0379
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [1] Interaction of Stem Cell Properties and DNA Repair determine the Radiosensitizing Effect after Inhibition of CHK1, RAD51 and PARP1 in TNBCs
    Meyer, F.
    Becker, S.
    Niecke, A.
    Werner, S.
    Peitzsch, C.
    Hein, L.
    Dubrovska, A.
    Goy, Y.
    Parplys, A.
    Petersen, C.
    Riepen, B.
    Zielinski, A.
    Rothkamm, K.
    Borgmann, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S9 - S9
  • [2] CHK1, RAD51 and PARP1 inhibition reduce the Radio Resistance of TNBC Tumor Stem Cells
    Meyer, F.
    Becker, S.
    Engel, A. M.
    Riepen, B.
    Peitzsch, C.
    Hein, L.
    Dubrovska, A.
    Wikmann, H.
    Windhorst, S.
    Petersen, C.
    Rothkamm, K.
    Borgmann, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S170 - S171
  • [3] The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition
    Mattiello, Luca
    Soliman Abdel Rehim, Sara
    Musella, Martina
    Sistigu, Antonella
    Guarracino, Andrea
    Vitale, Sara
    Corradi, Francesca
    Galassi, Claudia
    Sperati, Francesca
    Manic, Gwenola
    De Maria, Ruggero
    Vitale, Ilio
    CANCERS, 2021, 13 (08)
  • [4] 胃癌组织中RAD51及CHK1的表达及意义
    闫静波
    卫茹
    临床与实验病理学杂志, 2013, 29 (10) : 1128 - 1130
  • [5] Intratreatment Changes in RAD51 Foci Formation Predict Radiosensitization by PARP1 Inhibition in Breast Cancer Cell Lines
    Speers, C.
    Liu, M.
    Rinkinen, J.
    Albrecht-Unger, L.
    Jagsi, R.
    Pierce, L.
    Feng, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S695 - S696
  • [6] PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
    George E. Ronson
    Ann Liza Piberger
    Martin R. Higgs
    Anna L. Olsen
    Grant S. Stewart
    Peter J. McHugh
    Eva Petermann
    Nicholas D. Lakin
    Nature Communications, 9
  • [7] PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
    Ronson, George E.
    Piberger, Ann Liza
    Higgs, Martin R.
    Olsen, Anna L.
    Stewart, Grant S.
    McHugh, Peter J.
    Petermann, Eva
    Lakin, Nicholas D.
    NATURE COMMUNICATIONS, 2018, 9
  • [8] Exploring the effects of PARP inhibition on CHK1 activation as a potential determinant of synergy with CHK1 inhibition.
    Wielgos-Bonvallet, Monicka
    Cybulska, Paulina
    Van Oudenhove, Elke
    Jelinic, Petar
    Levine, Douglas A.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 28 - +
  • [9] CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling
    Pavan B Narayanaswamy
    Sergey Tkachuk
    Hermann Haller
    Inna Dumler
    Yulia Kiyan
    Cell Death & Disease, 2016, 7 : e2383 - e2383
  • [10] CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling
    Narayanaswamy, Pavan B.
    Tkachuk, Sergey
    Haller, Hermann
    Dumler, Inna
    Kiyan, Yulia
    CELL DEATH & DISEASE, 2016, 7 : e2383 - e2383
12345